Argos Therapeutics Inc (NASDAQ:ARGS)

8.40
Delayed Data
As of Apr 17
 -0.31 / -3.56%
Today’s Change
5.61
Today|||52-Week Range
10.80
-16.00%
Year-to-Date

Today’s Trading

Previous close8.71
Today’s open8.57
Day’s range8.40 - 8.76
Volume28,455
Average volume (3 months)31,433
Market cap$165.4M
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+87.30%
Earnings growth (this year)+5.02%
Earnings growth (next 5 years)--
Revenue growth (last year)-55.36%
P/E ratioNM
Price/Sales87.98
Price/Book5.27

Competitors

 Today’s
change
Today’s
% change
CERUCerulean Pharma Inc-0.23-3.64%
PVCTProvectus Biopharmac...+0.04+4.65%
GLYCGlycoMimetics Inc-0.14-1.61%
AKBAAkebia Therapeutics ...-0.36-4.15%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 13, 2015
EPS forecast (this quarter)-$0.77
Annual revenue (last year)$2.0M
Annual profit (last year)-$53.3M
Net profit margin-2,700.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
Chief Operating Officer &
VP-Manufacturing
Frederick M. Miesowicz
Corporate headquarters
Durham, North Carolina

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers